Sources | Names Used |
---|---|
CTRPv2 | salermide:PLX-4032 (12:1 mol/mol) |
PharmacoGx | salermide:PLX-4032 (12:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ABHD2 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
mRNA | ABHD6 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
mRNA | ABI1 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.03 |
mRNA | ABL2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
mRNA | AC004754.3 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.01 |
mRNA | AC005281.1 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.01 |
mRNA | AC006449.2 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
mRNA | AC006994.3 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |
mRNA | AC007326.1 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
mRNA | AC008074.1 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |